Skip to main content
Utility navigation
For Investors
Corporate Governance
Stock Information
Events
SEC Filings
Analyst Coverage
Investor Relations Contact
Annual Report
Investor Presentation
News
COVID-19 Candidate Updates
Press Releases & Statements
Novavax in the News
Join the Press Release List
Press Center
Contact Us
Careers
Careers - Sweden
Careers - Czech Republic
Contact Us
COVID-19 Candidate Updates
Main navigation
About Us
Our Team
Our Partners
Our Pipeline
COVID-19
Seasonal Influenza
Respiratory Syncytial Virus (RSV)
Ebola
Middle East Respiratory Syndrome (MERS)
Severe Acute Respiratory Syndrome (SARS)
Science and Technology
Our Approach
Our Science
Our Areas of Research
Our Unique Technology
Recombinant Nanoparticle Vaccine Technology
Matrix-M™ Adjuvant Technology
Resources
Clinical Trial Protocols
Publications
Posters
Presentations
Careers
